Oxidative damage and metabolic dysfunction in huntington's disease: Selective vulnerability of the basal ganglia

Annals of Neurology

Volumn 41, Issue 5, 1997, Pages 646-653

  Browne, Susan E ^a   Bowling, Allen C ^a   MacGarvey, Usha ^a   Baik, M Jay ^a   Berger, Stephanie C ^a   Muqit, Miratul M K ^a   Bird, Edward D ^b   Beal, M Flint ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b MCLEAN HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL NUCLEUS DNA; COPPER ZINC SUPEROXIDE DISMUTASE; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; HUNTINGTIN;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DEGENERATIVE DISEASE; DNA DAMAGE; ENZYME ACTIVITY; FEMALE; HUMAN; HUNTINGTON CHOREA; MALE; NERVE CELL NECROSIS; OXIDATIVE PHOSPHORYLATION; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION;

BASAL GANGLIA; CEREBELLUM; CEREBRAL CORTEX; DNA; GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASES; HUMANS; HUNTINGTON DISEASE; MITOCHONDRIA; NAD(P)H DEHYDROGENASE (QUINONE); OXIDATION-REDUCTION; REFERENCE VALUES; SPECTROPHOTOMETRY; STRESS; SUPEROXIDE DISMUTASE;

EID: 0030919567     PISSN: 03645134     EISSN: None     Source Type: Journal    
DOI: 10.1002/ana.410410514     Document Type: Article

References (38)

1. Beal MF. Does impairment of energy metabolism result in excitotoxic neuronal death in neurodegenerative illness? Ann Neurol 1992;31:119-130
2. Vonsattel J-P, Myers RH, Stevens TJ, et al. Neuropathological classification of Huntington's disease. J Neuropathol Exp Neurol 1985;44:559-577
3. The Huntington's Disease Collaborative Research Group. A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosome. Cell 1993; 72:971-983
4. Strong TV, Tagle DA, Valdes J, et al. Widespread expression of the human and rat Huntington's disease gene in brain and nonneuronal tissues. Nature Genet 1993;5:259-265
5. DiFiglia M, Sapp E, Chase K, et al. Huntingtin is a cytoplasmic protein associated with vesicles in human and rat brain neurons. Neuron 1995;14:1075-1081
6. Landwehrmeyer GB, McNeil SM, Dure LS, et al. Huntington's disease gene: regional and cellular expression in brain of normal and affected individuals. Ann Neurol 1995;37:218-230
7. Albin RL, Greenamyre JT. Alternative excitotoxic hypotheses. Neurology 1992;42:733-738
8. Kuhl DE, Markham CH, Metter EJ, et al. Local cerebral glucose utilization in symptomatic and presymptomatic Huntington's disease. Res Publ Assoc Res Nerv Ment Dis 1985;63:199-209
9. Mazziotta JC, Phelps ME, Pahl JJ, et al. Reduced cerebral glucose metabolism in asymptomatic patients at risk for Huntington's disease. N Engl J Med 1987;316:357-362
10. Leenders KL, Frackowiak RSJ, Quinn N, Marsden CD. Brain energy metabolism and dopaminergic function in Huntington's disease measured in vivo using positron emission tomography. Mov Disord 1986;1:69-77
11. Kuwert T, Lange HW, Langer K-J, et al. Cortical and subcortical glucose consumption measured by PET in patients with Huntington's disease. Brain 1990;113:1405-1423
12. Kuwert T, Lange HW, Boecker H, et al. Striatal glucose consumption in chorea-free subjects at risk of Huntington's disease. J Neurol 1993;241:31-36
13. Jenkins B, Koroshetz W, Beal MF, Rosen B. Evidence for an energy metabolism defect in Huntington's disease using localized proton spectroscopy. Neurology 1993;43:2689-2695
14. Stahl WL, Swanson PD. Biochemical abnormalities in Huntington's chorea brains. Neurology 1974;24:813-819
15. Butterworth J, Yates CM, Reynolds GP. Distribution of phosphate-activated glutaminase, succinic dehydrogenase, pyruvate dehydrogenase, and α-glutamyl transpeptidase in postmortem brain from Huntington's disease and agonal cases. J Neurol Sci 1985;67:161-171
16. Brennan WA, Bird ED, Aprille JR. Regional mitochondrial respiratory activity in Huntington's disease brain. J Neurochem 1985;44:1948-1950
17. Mann VM, Cooper JM, Javoy-Agid F, et al. Mitochondrial function and parental sex effect in Huntington's disease. Lancet 1990;336:749
18. Gu M, Gash MT, Mann VM, et al. Mitochondrial defect in Huntington's disease caudate nucleus. Ann Neurol 1996;39: 385-389
19. Burke JR, Enghild JJ, Martin ME, et al. Huntingtin and DRPLA proteins selectively interact with the enzyme GAPDH. Nature Med 1996;2:347-350
20. Lai JCK, Clark JB. Preparation of synaptic and nonsynaptic mitochondria from mammalian brain. Methods Enzymol 1979; 55:51-60
21. Hatefi Y. Preparation and properties of NADH: ubiquinone oxidoreductase (complex I), EC 1.6.5.3. Methods Enzymol 1978;53:11-14
22. Zheng X, Shoffner JM, Lott MT, et al. Evidence in a lethal infantile mitochondrial disease for a nuclear mutation affecting the respiratory complexes I and IV. Neurology 1989;39:1203-1209
23. Darley-Usmar VM, Rickwood D, Wilson MT. Mitochondria: a practical approach. Oxford: IRL Press, 1987
24. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976;72:248-254
25. Shepherd D, Garland PB. Citrate synthase from rat liver. Methods Enzymol 1969;13:11-16
26. Tabor CW, Tabor H, Rosenthal SM. Amine oxidases. J Biol Chem 1954;208:645-648
27. Heinz F, Freimuller B. Glyceraldehyde-3-phosphate dehydrogenase from human tissues. Methods Enzymol 1982;89:301-305
28. Mecocci P, MacGarvey U, Kaufman AE, et al. Oxidative damage to mitochondrial DNA shows marked age-dependent increases in human brain. Ann Neurol 1993;34:609-616
29. Misra HP, Fridovich I. The univalent reduction of oxygen by reduced flavins and quinones. J Biol Chem 1972;247:188-192
30. Vila M, Levy R, Herrero M-T, et al. Metabolic activity of the basal ganglia in parkinsonian syndromes in human and nonhuman primates: a cytochrome oxidase histochemistry study. Neuroscience 1996;71:903-912
31. Beal MF, Hymen BT, Koroshetz W. Do defects in mitochondrial energy metabolism underlie the pathology of neurodegenerative diseases? Trends Neurosci 1994;16:125-131
32. Riepe MW, Hori N, Ludolph AC, Carpenter DO. Failure of neuronal ion exchange, not potentiated excitation, causes excitotoxicity after inhibition of oxidative phosphorylation. Neuroscience 1995;64:91-97
33. Novelli A, Reilly JA, Lysko PG, Henneberry RC. Glutamate becomes neurotoxic via the N-methyl-D-aspartate receptor when intracellular energy levels are reduced. Brain Res 1988;451: 205-212
34. Zeevalk GD, Nicklas WJ. Mechanisms underlying initiation of excitotoxicity associated with metabolic inhibition. J Pharmacol Exp Ther 1991;257:870-878
35. Henneberry RL, Novelli A, Cox JA, Lysko PG. Neurotoxicity at the N-methyl-D-aspartate receptor in energy-compromised neurons. An hypothesis for cell death in aging and disease. Ann NY Acad Sci 1989;568:225-233
36. Mettler FA. Choreoathetosis and striopallidal necrosis due to sodium azide. Exp Neurol 1972;34:291-308
37. Bourgeron T, Rustin P, Chretien D, et al. Mutation of a nuclear succinate dehydrogenase gene results in mitochondrial respiratory chain deficiency. Nature Genet 1995;11:144-149
38. Martin JJ, Van de Vyver FL, Scholte HR, et al. Defect in succinate oxidation by isolated muscle mitochondria in a patient with symmetrical lesions in the basal ganglia. J Neurol Sci 1988;84:189-200